These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 17196303)

  • 1. Possible involvement of endogenous nociceptin/orphanin FQ in the pain-related behavioral responses induced by its own metabolite, nociceptin/orphanin FQ(14-17).
    Watanabe H; Mizoguchi H; Orito T; Katsuyama S; Yonezawa A; Watanabe C; Sakurada T; Sakurada S
    Peptides; 2007 Mar; 28(3):670-7. PubMed ID: 17196303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinociceptive effects of spinally administered nociceptin/orphanin FQ and its N-terminal fragments on capsaicin-induced nociception.
    Katsuyama S; Mizoguchi H; Komatsu T; Sakurada C; Tsuzuki M; Sakurada S; Sakurada T
    Peptides; 2011 Jul; 32(7):1530-5. PubMed ID: 21672568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The putative OP(4) antagonist, [Nphe(1)]nociceptin(1-13)NH(2), prevents the effects of nociceptin in neuropathic rats.
    Corradini L; Briscini L; Ongini E; Bertorelli R
    Brain Res; 2001 Jun; 905(1-2):127-33. PubMed ID: 11423087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nocistatin: a novel neuropeptide encoded by the gene for the nociceptin/orphanin FQ precursor.
    Okuda-Ashitaka E; Ito S
    Peptides; 2000 Jul; 21(7):1101-9. PubMed ID: 10998544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orphanin FQ/nociceptin interacts with the basolateral amygdala noradrenergic system in memory consolidation.
    Roozendaal B; Lengvilas R; McGaugh JL; Civelli O; Reinscheid RK
    Learn Mem; 2007; 14(1-2):29-35. PubMed ID: 17202427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of nociceptin/orphanin FQ-induced pain responses by the novel receptor antagonist N-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl) benzamide monohydrochloride.
    Muratani T; Minami T; Enomoto U; Sakai M; Okuda-Ashitaka E; Kiyokane K; Mori H; Ito S
    J Pharmacol Exp Ther; 2002 Oct; 303(1):424-30. PubMed ID: 12235279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central administration of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)-NH2 and orphanin FQ/nociceptin (OFQ/N) produce similar cardiovascular and renal responses in conscious rats.
    Kapusta DR; Chang JK; Kenigs VA
    J Pharmacol Exp Ther; 1999 Apr; 289(1):173-80. PubMed ID: 10087001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional antagonism between nociceptin/orphanin FQ and corticotropin-releasing factor in rat anxiety-related behaviors: involvement of the serotonergic system.
    Filaferro M; Ruggieri V; Novi C; Calò G; Cifani C; Micioni Di Bonaventura MV; Sandrini M; Vitale G
    Neuropeptides; 2014 Aug; 48(4):189-97. PubMed ID: 24894718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of orphanin FQ/nociceptin and its fragments.
    Rossi GC; Leventhal L; Bolan E; Pasternak GW
    J Pharmacol Exp Ther; 1997 Aug; 282(2):858-65. PubMed ID: 9262352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nociceptin/orphanin FQ into the rat periaqueductal gray decreases the withdrawal latency to heat and loading, an effect reversed by (Nphe(1))nociceptin(1-13)NH(2).
    Bytner B; Huang YH; Yu LC; Lundeberg T; Nylander I; Rosen A
    Brain Res; 2001 Dec; 922(1):118-24. PubMed ID: 11730709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of nociceptin/orphanin FQ and its receptor in electroacupuncture-produced anti-hyperalgesia in rats with peripheral inflammation.
    Fu X; Wang YQ; Wu GC
    Brain Res; 2006 Mar; 1078(1):212-8. PubMed ID: 16563360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nociceptin/orphanin FQ and [Phe(1)psi(CH2-NH)Gly2]nociceptin(1-13)NH2 modulates the activity of hypothalamic paraventricular nucleus neurons in vitro.
    Shirasaka T; Miyahara S; Takasaki M; Kannan H
    Brain Res; 2001 Jan; 890(1):147-53. PubMed ID: 11164777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nocistatin and prepro-nociceptin/orphanin FQ 160-187 cause nociception through activation of Gi/o in capsaicin-sensitive and of Gs in capsaicin-insensitive nociceptors, respectively.
    Inoue M; Kawashima T; Allen RG; Ueda H
    J Pharmacol Exp Ther; 2003 Jul; 306(1):141-6. PubMed ID: 12665541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between nociceptin/orphanin FQ (N/OFQ) and GABA in response to feeding.
    Tajalli S; Jonaidi H; Abbasnejad M; Denbow DM
    Physiol Behav; 2006 Oct; 89(3):410-3. PubMed ID: 16904711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of proinflammatory cytokines gene expression by nociceptin/orphanin FQ in the spinal cord and the cultured astrocytes.
    Fu X; Zhu ZH; Wang YQ; Wu GC
    Neuroscience; 2007 Jan; 144(1):275-85. PubMed ID: 17069983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ORL-1 (NOP1) receptor ligand nociceptin/orphanin FQ (N/OFQ) inhibits neurogenic dural vasodilatation in the rat.
    Bartsch T; Akerman S; Goadsby PJ
    Neuropharmacology; 2002 Nov; 43(6):991-8. PubMed ID: 12423668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of NMDA receptor in nociceptive effects elicited by intrathecal [Tyr6] gamma2-MSH(6-12), and the interaction with nociceptin/orphanin FQ in pain modulation in mice.
    Chang M; Li W; Peng YL; Gao YH; Yao J; Han RW; Wang R
    Brain Res; 2009 May; 1271():36-48. PubMed ID: 19332041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carboxyl terminal peptides derived from prepro-orphanin FQ/nociceptin (ppOFQ/N) are produced in the hypothalamus and possess analgesic bioactivities.
    Mathis JP; Rossi GC; Pellegrino MJ; Jimenez C; Pasternak GW; Allen RG
    Brain Res; 2001 Mar; 895(1-2):89-94. PubMed ID: 11259764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic nociceptin/orphanin FQ exposure on cAMP accumulation and receptor density in Chinese hamster ovary cells expressing human nociceptin/orphanin FQ receptors.
    Hashimoto Y; Calo' G; Guerrini R; Smith G; Lambert DG
    Eur J Pharmacol; 2002 Aug; 449(1-2):17-22. PubMed ID: 12163101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orphanin FQ/nociceptin and [Phe(1)Psi(CH(2)-NH)Gly(2)] nociceptin(1-13)-NH(2) stimulate gastric motor function in anaesthetized rats.
    Krowicki ZK; Kapusta DR; Hornby PJ
    Br J Pharmacol; 2000 Aug; 130(7):1639-45. PubMed ID: 10928969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.